GW Pharmaceuticals plc (Nasdaq: GWPH) announced today that it intends to sell, subject to market and other conditions, $225 million ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE